CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+4.74%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$601M
AUM Growth
+$601M
(-13%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-7.53%
Top 10 Holdings %
Top 10 Hldgs %
45.47%
Holding
85
New
9
Increased
4
Reduced
19
Closed
15
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$28.9M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$16.9M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$15.5M |
| 4 |
Omeros
OMER
|
$10.9M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.97M |
Top Sells
| 1 |
Theravance Biopharma
TBPH
|
$18.9M |
| 2 |
Corbus Pharmaceuticals
CRBP
|
$13.9M |
| 3 |
FWP
Forward Pharma A/S American Depositary Shares
FWP
|
$12.7M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$11.8M |
| 5 |
ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
|
$10.1M |
Sector Composition
| 1 | Healthcare | 84.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Syndax Pharmaceuticals
SNDX
$1.39B
| – | – |
-240,403
| Closed | -$3.3M |
|
|
VIRX
77
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-14,862
| Closed | -$2.13M |
|
|
ZYNE
78
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| – | – |
-500,000
| Closed | -$10.1M |
|
|
SYNH
79
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-200,000
| Closed | -$9.17M |
|
|
EPZM
80
DELISTED
Epizyme, Inc
EPZM
| – | – |
-140,000
| Closed | -$2.4M |
|
|
AVEO
81
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| – | – |
-70,000
| Closed | -$413K |
|
|
FWP
82
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| – | – |
-84,168
| Closed | -$12.7M |
|
|
TIG
83
DELISTED
TiGenix American Depositary Shares
TIG
| – | – |
-129,032
| Closed | -$2.01M |
|
|
AVXS
84
DELISTED
AveXis, Inc. Common Stock
AVXS
| – | – |
-30,000
| Closed | -$2.28M |
|
|
CBPO
85
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| – | – |
-100,000
| Closed | -$10M |
|